Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.55 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5075953 | 0.93 | HIF1A (0.58) | HIF1AMRGPRX4SCN9AMEN1KMT2A | |
| SCHEMBL5074518 | 0.91 | HIF1A (0.45) | HIF1AMRGPRX4SCN9AMEN1KMT2A | |
| SCHEMBL5074511 | 0.91 | HIF1A (0.45) | HIF1AMRGPRX4SCN9AMEN1KMT2A | |
| SCHEMBL5074499 | 0.85 | HIF1A (0.38) | HIF1AMRGPRX4SCN9AMEN1KMT2A | |
| SCHEMBL6150542 | 0.84 | HIF1A (0.48) | HIF1AMRGPRX4TP53HTTMAOA | |
| SCHEMBL6150541 | 0.84 | HIF1A (0.48) | HIF1AMRGPRX4TP53HTTMAOA | |
| SCHEMBL5076937 | 0.84 | HIF1A (0.37) | HIF1AMRGPRX4SCN9AMEN1KMT2A | |
| SCHEMBL5076000 | 0.84 | HIF1A (0.47) | HIF1AMRGPRX4SCN9AMEN1KMT2A | |
| SCHEMBL5075996 | 0.84 | HIF1A (0.47) | HIF1AMRGPRX4SCN9AMEN1KMT2A | |
| SCHEMBL5074501 | 0.83 | HIF1A (0.35) | HIF1AMRGPRX4SCN9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435844-B2 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2008-10-14 | — | — | US | disclosed |
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2006-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | DDT, RYR1, TPMT | HIF1A 4554/4885MRGPRX4 989/4885SCN9A 1765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.